Equity Profile

DVA

DaVita Inc.

Health CareHealth Care Services$11.4B

Aug5Wed

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

DaVita Inc. is a leading provider of kidney care services in the healthcare sector....

Key Metrics to Watch

EPS (Earnings Per Share)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

Expected to be around $2.87.

Revenue Growth

Revenue growth reflects the company's ability to expand its services and manage costs effectively, impacting overall performance.

Not available.

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

DVA Q2-2026 Earnings Preview

Context

Company Snapshot

DaVita Inc. is a leading provider of kidney care services in the healthcare sector. With a focus on dialysis services for patients with chronic kidney failure, DaVita plays a crucial role in managing a significant health issue affecting millions of Americans.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+3.03%

Avg Stock Reaction

+0.92%

Last Quarter Recap

In Q1 2026, DaVita reported an EPS of $2.87, surpassing expectations by 19%. The stock reacted positively, gaining nearly 2% the following day.

Management Promises & Guidance

Focus on improving patient care and expanding service offerings.
Commitment to cost management and operational efficiency.
Plans to enhance technology integration in patient care.

Expectations

Wall Street Expectations

Overall, analysts expect DaVita to continue its trend of beating earnings estimates, driven by strong operational performance and patient growth.

Bull Case

If DaVita can demonstrate robust patient growth and manage costs effectively, it could lead to higher-than-expected earnings and a positive stock reaction.

Bear Case

Conversely, any signs of slowing patient growth or rising operational costs could lead to disappointing earnings and a negative market reaction.

Key Metrics to Watch

EPS (Earnings Per Share)

Expected to be around $2.87.

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

Revenue Growth

Not available.

Revenue growth reflects the company's ability to expand its services and manage costs effectively, impacting overall performance.

Patient Growth

Not available.

The number of patients served is critical for DaVita's growth strategy and revenue generation.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the current patient growth rate and how does it compare to previous quarters?

Patient growth is a key driver of revenue and profitability, and any slowdown could raise concerns among investors.

How is DaVita managing operational costs in the current economic environment?

Cost management is crucial for maintaining margins, especially in a sector facing rising expenses.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating DaVita's ability to manage costs effectively while maintaining patient growth, which could lead to better-than-expected earnings.

Supporting Evidence

DaVita has consistently beaten EPS estimates in recent quarters, indicating strong operational execution.

Options pricing suggests a significant move, which may reflect investor uncertainty rather than a bearish outlook.

The company's focus on technology integration could enhance efficiency and patient care, driving growth.

Key Risk

If patient growth exceeds 5%, it could significantly shift the market's perception of DaVita's growth potential.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating DaVita's ability to sustain growth amidst rising healthcare costs and competition.

Bull Confirmed If

Demonstrating patient growth of over 5% YoY would confirm the bull case.

Bear Confirmed If

Any decline in patient numbers or significant increase in operational costs would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±19.68%

Historical Avg

±1.5%

Pricing rich

The options market is pricing in a significant move, indicating that investors expect volatility around the earnings announcement.

Options are pricing ±19.7% while DVA has averaged ±1.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

65.2%

Calls (38K)P/C Ratio: 0.55Puts (4K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If DaVita beats expectations, history suggests a potential stock increase of around 1.48%, confirming strong operational performance.

In-Line / Cautious

An in-line report with cautious commentary could lead to muted reactions, as the market assesses future growth prospects.

Miss

If the company misses earnings expectations, history suggests a potential decline of about 0.78%, raising concerns about growth.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on patient growth metrics and how they compare to industry trends.
2Details on cost management strategies and their effectiveness.
3Any new initiatives in technology integration for patient care.
4Management's outlook on the competitive landscape in kidney care services.
5Insights into regulatory changes that could impact operations.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

DaVita Inc. is a leading provider of kidney care services in the healthcare sector....

Key Metrics to Watch

EPS (Earnings Per Share)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

Expected to be around $2.87.

Revenue Growth

Revenue growth reflects the company's ability to expand its services and manage costs effectively, impacting overall performance.

Not available.

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

DVA Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+3.03%

Avg Stock Reaction

+0.92%

Last Quarter Recap

In Q1 2026, DaVita reported an EPS of $2.87, surpassing expectations by 19%. The stock reacted positively, gaining nearly 2% the following day.

Management Promises & Guidance

Focus on improving patient care and expanding service offerings.
Commitment to cost management and operational efficiency.
Plans to enhance technology integration in patient care.

Expectations

Wall Street Expectations

Overall, analysts expect DaVita to continue its trend of beating earnings estimates, driven by strong operational performance and patient growth.

Bull Case

If DaVita can demonstrate robust patient growth and manage costs effectively, it could lead to higher-than-expected earnings and a positive stock reaction.

Bear Case

Conversely, any signs of slowing patient growth or rising operational costs could lead to disappointing earnings and a negative market reaction.

Key Metrics to Watch

EPS (Earnings Per Share)

Expected to be around $2.87.

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

Revenue Growth

Not available.

Revenue growth reflects the company's ability to expand its services and manage costs effectively, impacting overall performance.

Patient Growth

Not available.

The number of patients served is critical for DaVita's growth strategy and revenue generation.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the current patient growth rate and how does it compare to previous quarters?

Patient growth is a key driver of revenue and profitability, and any slowdown could raise concerns among investors.

How is DaVita managing operational costs in the current economic environment?

Cost management is crucial for maintaining margins, especially in a sector facing rising expenses.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating DaVita's ability to manage costs effectively while maintaining patient growth, which could lead to better-than-expected earnings.

Supporting Evidence

DaVita has consistently beaten EPS estimates in recent quarters, indicating strong operational execution.

Options pricing suggests a significant move, which may reflect investor uncertainty rather than a bearish outlook.

The company's focus on technology integration could enhance efficiency and patient care, driving growth.

Key Risk

If patient growth exceeds 5%, it could significantly shift the market's perception of DaVita's growth potential.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating DaVita's ability to sustain growth amidst rising healthcare costs and competition.

Bull Confirmed If

Demonstrating patient growth of over 5% YoY would confirm the bull case.

Bear Confirmed If

Any decline in patient numbers or significant increase in operational costs would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±19.68%

Historical Avg

±1.5%

Pricing rich

The options market is pricing in a significant move, indicating that investors expect volatility around the earnings announcement.

Options are pricing ±19.7% while DVA has averaged ±1.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

65.2%

Calls (38K)P/C Ratio: 0.55Puts (4K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If DaVita beats expectations, history suggests a potential stock increase of around 1.48%, confirming strong operational performance.

In-Line / Cautious

An in-line report with cautious commentary could lead to muted reactions, as the market assesses future growth prospects.

Miss

If the company misses earnings expectations, history suggests a potential decline of about 0.78%, raising concerns about growth.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on patient growth metrics and how they compare to industry trends.
2Details on cost management strategies and their effectiveness.
3Any new initiatives in technology integration for patient care.
4Management's outlook on the competitive landscape in kidney care services.
5Insights into regulatory changes that could impact operations.